Healthcare Professionals

Inspired by nature.

Adopted by science.

Discover Anasa-A & Anasa-C through the documented action of their ingredients.

Respiratory health is a modern intergenerational concern. From allergies and pollution to the repeated use of pharmaceutical preparations, respiratory health is a challenge across generations.

Anasa-A and Anasa-C offer a new, natural alternative for those seeking effective respiratory support — with formulations based on scientifically documented botanical actives with a history of clinical application

Documented characteristics

  • Contain ingredients with recognized efficacy supported by peer-reviewed studies (Boswellia, Perilla, Sambucus, Glutathione, Zinc).
  • Sugar-free, with no pharmacologically active substances.
  • Suitable for advisory recommendation without prescription.
  • Manufactured in Greece according to EU-GMP regulations.
  • Supported by educational materials for physicians and pharmacists (PDFs, brochures, FAQs).

For Healthcare Professionals

The Anasa range has been developed with reliability and botanical precision in mind.

Below is a concise presentation of the key active ingredients and the clinical documentation supporting their use in daily practice.

Anasa-A
Clinical Documentation

Boswellia serrata:

Boswellic acids have proven anti-inflammatory activity through inhibition of 5-lipoxygenase.
They may help alleviate symptoms of asthma and COPD.
(Ammon 2002, Kokkinis 2024)

Perilla frutescens:

Plant extract shown to inhibit neutrophil activity and reduce free radical production, positively influencing the inflammatory response of the respiratory tract.
(Zekonis 2008)

Astragalus membranaceus: Enhances the body’s natural immune defence and reduces the impact of allergens.

Βιταμίνη B2: Plays a role in maintaining the normal condition of mucous membranes, according to EFSA.
(EFSA Journal 2009; 7(9):1215)

Anasa-C
Clinical Documentation

Boswellia serrata: Boswellic acids have proven anti-inflammatory activity via inhibition of 5-lipoxygenase.
They may contribute to relief of asthma and COPD symptoms.
(Ammon 2002, Kokkinis 2024)

Sambucus nigra:

Clinical trials with Sambucus nigra lozenges (175 mg), 4 times daily, demonstrated statistically significant improvement in viral infection symptoms within 48 hours.
(Mahboubi 2021, PMC7347422)

Zinc sulfate: Demonstrates antioxidant, anti-inflammatory, and immunomodulatory activity in respiratory conditions ranging from asthma to pulmonary fibrosis.
(Liu 2022, Luan 2022)

Παρεχόμενο υλικό:

  • Επιστημονικό Dossier (PDF)

  • Δράση αναλυτικά ανά συστατικό

  • Προτεινόμενη δοσολογία ανά προφίλ ασθενούς

  • Παραπομπές σε βιβλιογραφία & μελέτες

  • Αίτηση για δείγματα (μόνο για επαγγελματίες)

Ideal for:

  • ENT specialists, pulmonologists, and general practitioners
  • Pharmacists recommending natural or botanical preparations
  • Nutritionists seeking targeted, functional supplements
  • Family medicine or paediatric physicians (for patients aged 12+)
  • Rehabilitation and respiratory wellness specialists / wellness clinics
  •  

Scientific integrity

Anasa formulations do not replace standard medical treatment or a balanced diet.
However, they may enhance overall immune response and improve patients’ daily wellbeing as part of a holistic approach to health.